Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]        
Product revenue $ 3,378 $ 4,835 $ 11,574 $ 14,358
Costs of revenue 765 1,640 2,675 4,525
Gross profit 2,613 3,195 8,899 9,833
Operating expenses:        
Research and development 1,582 1,676 4,743 5,072
General and administrative 1,912 1,432 4,834 4,793
Sales and marketing 2,326 2,893 7,514 9,376
Total operating expenses 5,820 6,001 17,091 19,241
Loss from operations (3,207) (2,806) (8,192) (9,408)
Other income (expense):        
Interest expense (745) (1,147) (3,998) (3,381)
Gain (loss) on extinguishment of debt (417) 2,403 (661) 2,324
Change in fair value of derivative liabilities 26 (7,779) 50 (8,879)
Loss on extinguishment of derivative liabilities (2) (1,263)
Offering costs (821) (821)
Other expense 5 19 11 (19)
Total other expense, net (1,131) (7,327) (4,598) (12,039)
Net loss before income taxes (4,338) (10,133) (12,790) (21,447)
Provision for income taxes
Net comprehensive loss (4,338) (10,133) (12,790) (21,447)
Other comprehensive loss, net of tax:        
Total comprehensive loss (4,338) (10,133) (12,790) (21,447)
Deemed dividend related to beneficial conversion feature and accretion of a discount on Series A Preferred Stock (6,278) (6,278)
Net loss attributable to common stockholders $ (10,616) $ (10,133) $ (19,068) $ (21,447)
Net loss per share attributable to common stockholders:        
Basic and diluted $ (0.46) $ (2.21) $ (1.21) $ (6.41)
Weighted average common shares outstanding:        
Basic and diluted 23,048,941 4,575,302 15,711,429 3,343,695